Quadridox Inc.

Quadridox Inc. is a for-profit organization specializing in advanced medical imaging technology research and development, with a particular focus on X-ray imaging systems. The company leverages its expertise in medical X-ray imaging to create innovative solutions for both security and healthcare applications, serving federal agencies through prime contracts, grants, subcontracts, and subgrants. Quadridox's core competency lies in developing cutting-edge X-ray transmission and diffraction imaging systems for various applications, including explosive detection, cancer specimen analysis, and biomedical research. Their work spans multiple sectors, demonstrating the versatility of their technology in addressing diverse challenges in security screening and medical diagnostics.

In the realm of federal contracts, Quadridox has secured significant prime awards from the Department of Homeland Security's Science and Technology Directorate. A notable example is a $5,680,620.94 cost-plus-fixed-fee definitive contract awarded in February 2024 for the development of a low false alarm, high throughput hybrid CT+ X-ray diffraction imaging explosive detection system. This project, set to be performed in Durham, North Carolina through February 2027, showcases Quadridox's ability to apply their medical imaging expertise to security applications. Additionally, the company was awarded another contract worth $2,346,459.81 in September 2024 for the development of a "Tabletop Threat Resolution Using Transmitted and Diffracted X-Rays" solution, further solidifying their role in creating innovative security screening technologies. Quadridox has also served as a subcontractor to Leidos, Inc., providing goods and services in support of a contract with an unspecified federal agency. It's worth noting that these contract awards did not have any set-aside designations, indicating the company's competitiveness in open bidding processes.

Quadridox has also secured substantial federal grant funding for its research and development efforts in the medical field. The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the company a $1,762,942 Project Grant in September 2023 under the Discovery and Applied Research for Technological Innovations to Improve Human Health program. This grant supports the development and evaluation of a combined X-ray transmission and diffraction imaging system for rapid, non-destructive pathology screening of cancer specimens. Another significant grant from the National Cancer Institute, awarded in May 2021, funds the development of a multimodality X-ray transmission and diffraction scanner for molecular analysis of cancer specimens. This project aims to create a laboratory-accessible tool for high-resolution, high-specificity analysis of biospecimens. Interestingly, Quadridox appears as both a prime grantee and a subgrantee on related projects, collaborating with institutions like Duke University. In its subgrantee role, Quadridox provides expertise in scanner technology design, development, testing, and validation, as well as assistance with implementation of reconstruction algorithms and data analysis, demonstrating their comprehensive involvement in advancing X-ray imaging technology for cancer research and clinical applications.